Sleep in Patients With Cystic Fibrosis (Sommeil)
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
The aim of the study is to identify the parameters that are associated with nocturnal hypoventilation in children and adults with cystic fibrosis. Included patients will undergo a nocturnal evaluation of their gas exchange and sleep quality by actigraphy during their annual check up. The aim is thus to identify which parameters (such as lung function parameters) are associated with nocturnal hypercapnia or hypoxemia and/or poor sleep quality
| Condition | Intervention |
|---|---|
|
Cystic Fibrosis |
Device: SENTEC device |
| Study Type: | Observational |
| Study Design: | Observational Model: Cohort Time Perspective: Cross-Sectional |
| Official Title: | Predictors of Nocturnal Hypoventilation in Patients With Cystic Fibrosis |
- To determine clinical and functional parameters associated with nocturnal hypoventilation defined by· - A mean transcutaneous carbon dioxide pressure (PtcCO2) ≥ 45 mm Hg· - And/or a maximal PtcCO2 ≥ 55 mm Hg· - And/or a PtcCO2 ≥ 45 mm Hg during ≥ 50% [ Time Frame: At the inclusion visit ] [ Designated as safety issue: No ]
- To determine clinical and functional parameters associated with- sleep -disordered breathing defined by the presence of arousals on actigraphy (Actiwatch™) in children and adults with CF - nocturnal hypoxemia defined by -- a mean pulse oximetry (SaO2) [ Time Frame: At the inclusion visit ] [ Designated as safety issue: No ]
| Enrollment: | 76 |
| Study Start Date: | July 2007 |
| Study Completion Date: | June 2009 |
| Primary Completion Date: | June 2009 (Final data collection date for primary outcome measure) |
| Groups/Cohorts | Assigned Interventions |
|---|---|
|
1
Children and adults with cystic fibrosis
|
Device: SENTEC device
Nocturnal recording SAO2 and PtcCO2 and wrist movements by means of actigraphy
Other Name: Nocturnal SAO2/PtcCO2 and wrist movements
|
Detailed Description:
Background In patients with cystic fibrosis (CF), respiratory disease is characterised by a progressive and ineluctable decline in lung function. Sleep-disordered breathing may occur at an early stage of lung disease and may impair quality of life. Oxygen therapy or noninvasive positive pressure ventilation may improve nocturnal hypoxemia and hypercapnia.Risk factors for nocturnal hypercapnia or hypoxemia are not well identified in patients with CF.
Type of study : prospective, transversal, open
Methods :
During the annual check up, a sleep study will be performed with a nocturnal recording of a least 6 hours of pulse oximetry (SaO2) and transcutaneous carbon dioxide (PtcCO2) by the SENTEC device and wrist movements by means of actigraphy. The results of the sleep study will be correlated to·
- clinical scores which evaluate sleep quality (such as the PITTSBURG Sleep Quality Score).·
- respiratory function parameters : lung volumes, forced expiratory of the respiratory muscles: maximal inspiratory and expiratory pressures and the sniff nasal inspiratory pressure.·
- nutritional state with the body mass index z-score·
- the presence of arterial pulmonary hypertension on an echocardiography·
- infectious status (colonisation by Staphylococcus aureus or Pseudomonas aeruginosa) and the CFTR genotype.
Expected results This study should be able to document abnormal nocturnal gas exchange and sleep-disordered breathing in patients with CF in a stable state. The identification of parameters associated with nocturnal hypoventilation and/or poor sleep quality will help to screen those patients who will need a sleep study and treatment such as oxygen therapy or noninvasive positive pressure ventilation.
Eligibility| Ages Eligible for Study: | 8 Years and older |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | No |
| Sampling Method: | Non-Probability Sample |
Patients from the pneumology centers participating to the study
Inclusion Criteria:
- children > 8 years and adults with CF
- in a stable state (no acute respiratory exacerbation since one month or patient finishing an antibiotic course)
- able to perform reproducible forced expiratory flows
- having a forced expiratory volume in one second ≤ 60% predicted value
- who accepts to perform a sleep study in the hospital during one night
- written agreement to participate to the study
Exclusion Criteria:
- acute respiratory exacerbation in the previous month or patient who has not finished an antibiotic course
- Inability or impossibility to perform reproducible forced expiratory flows (pneumothorax during the previous year and/or without surgery)
- having a forced expiratory volume in one second > 60% predicted value
- refusal or impossibility to perform a sleep study in the hospital during one night
- patients receiving long term oxygen therapy or noninvasive positive pressure ventilation
- no social security
- impossibility of a medical examination
Contacts and Locations| France | |
| AP-HP, Armand Trousseau hospital | |
| Paris, France, 75012 | |
| Principal Investigator: | Brigitte Fauroux, MD | Assistance Publique - Hôpitaux de Paris |
More Information
No publications provided
| Responsible Party: | Yannick Vacher, Department Clinical Research of Developpement |
| ClinicalTrials.gov Identifier: | NCT00804661 History of Changes |
| Other Study ID Numbers: | P070202 |
| Study First Received: | December 8, 2008 |
| Last Updated: | June 2, 2010 |
| Health Authority: | France: Ministry of Health |
Keywords provided by Assistance Publique - Hôpitaux de Paris:
|
sleep nocturnal hypoventilation sleep quality lung function |
Additional relevant MeSH terms:
|
Cystic Fibrosis Fibrosis Hypoventilation Pancreatic Diseases Digestive System Diseases Lung Diseases Respiratory Tract Diseases |
Genetic Diseases, Inborn Infant, Newborn, Diseases Pathologic Processes Respiratory Insufficiency Respiration Disorders Signs and Symptoms, Respiratory Signs and Symptoms |
ClinicalTrials.gov processed this record on May 21, 2013